1. India Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Ind-Swift Laboratories Limited

Ind-Swift Laboratories Limited

INDSWFTLAB.NS
Ind-Swift Laboratories LimitedIN flagNational Stock Exchange of India
157.11
INR
-4.99
- -
13.64BMarket Cap

Total Valuation

Ind-Swift Laboratories Limited carries a market capitalization of 13.64B, placing it among publicly traded companies globally. Its enterprise value stands at 1.36B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap13.64B
Enterprise Value1.36B

Share Statistics

Ind-Swift Laboratories Limited currently has 60.62M shares outstanding.

Shares Outstanding60.62M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Ind-Swift Laboratories Limited trades at a trailing price-to-earnings ratio of 2.46. The price-to-sales ratio is 1.21, and the price-to-book ratio stands at -7.94.

PE Ratio2.46
PS Ratio1.21
PB Ratio-7.94
P/TBV Ratio0.47
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, Ind-Swift Laboratories Limited trades at an EV/EBITDA multiple of 22.90 and an EV/FCF ratio of 6.73. The EV/Sales ratio of 0.30 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 22.90 provides insight into valuation relative to core operating earnings.

EV / Sales0.30
EV / EBITDA22.90
EV / EBIT22.90
EV / FCF6.73

Financial Position

Ind-Swift Laboratories Limited maintains a current ratio of 3.92, meaning it holds 3.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 3.48, indicating elevated leverage, while an interest coverage ratio of -1.78 demonstrates limited ability to service its debt obligations.

Current Ratio3.92
Quick Ratio2.05
Debt / Equity3.48
Debt / EBITDA-1.10
Interest Coverage-1.78

Financial Efficiency

Ind-Swift Laboratories Limited posts a return on equity of 731.50 and a return on invested capital of -3.27.

Return on Equity (ROE)731.50
Return on Assets (ROA)16.92
Return on Invested Capital (ROIC)-3.27
Return on Capital Employed (ROCE)1,020.98
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover3.63

Taxes

Over the trailing twelve months, Ind-Swift Laboratories Limited has paid 72.70M in income taxes, reflecting an effective tax rate of 3.17.

Income Tax72.70M
Effective Tax Rate3.17

Stock Price Statistics

Ind-Swift Laboratories Limited's stock has gained approximately 78.14945% over the past 52 weeks. The 50-day moving average sits at 139.18, while the 200-day moving average is 116.72.

Beta (5Y)N/A
52-Week Price Change78.14945%
50-Day Moving Average139.18
200-Day Moving Average116.72
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Ind-Swift Laboratories Limited generated 4.53B in revenue and converted that into 2.22B in net income, yielding earnings per share of 33.65. EBITDA reached -369.88M, while operating income came in at -369.88M.

Revenue4.53B
Gross Profit2.28B
Operating Income-369.88M
Pretax Income2.30B
Net Income2.22B
EBITDA-369.88M
EBIT-369.88M
Earnings Per Share (EPS)33.65

Balance Sheet

Ind-Swift Laboratories Limited holds 4.51B in cash and equivalents against 408.56M in total debt, resulting in a net debt position of -3.71B. Total book value stands at -687.95M, with working capital of 6.45B providing operational flexibility.

Cash & Cash Equivalents4.51B
Total Debt408.56M
Net Debt-3.71B
Equity (Book Value)-687.95M
Book Value Per Share-10.57
Working Capital6.45B

Margins

Ind-Swift Laboratories Limited operates with a gross margin of 50.46, reflecting its pricing power and cost economics. The operating margin of -8.17 and net profit margin of 49.10 provide insight into operational efficiency.

Gross Margin50.46
Operating Margin-8.17
Pretax Margin50.72
Profit Margin49.10
EBITDA Margin-8.17

Scores

Ind-Swift Laboratories Limited posts an Altman Z-Score of 1.87, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score1.87